Crexendo (CXDO) director David Roy Williams granted 10,000 stock options

Rhea-AI Filing Summary

Crexendo, Inc. director David Roy Williams reported receiving a grant of stock options. The award covers 10,000 stock options with an exercise price of $6.47 per share. According to the disclosure, these options vest in 36 equal monthly installments beginning on April 4, 2026, meaning the director earns the right to exercise a portion of the options each month over three years. Following this grant, Williams is shown as holding 10,000 stock options directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams David Roy

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$6.47	03/04/2026		A		10,000		(1)	03/04/2036	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

	/s/David R. Williams	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Crexendo (CXDO) director David Roy Williams report?

David Roy Williams reported an acquisition of stock options in Crexendo. He was granted 10,000 stock options with an exercise price of $6.47 per share, recorded as a direct ownership award under a grant or other acquisition transaction.

What are the key terms of the Crexendo (CXDO) stock options granted to David Roy Williams?

The grant to David Roy Williams consists of 10,000 stock options with an exercise price of $6.47 per share. These options are held directly and classified as a grant, award, or other acquisition rather than an open-market purchase or sale.

How do the Crexendo (CXDO) stock options granted to David Roy Williams vest?

The stock options granted to David Roy Williams vest in 36 equal monthly installments beginning on April 4, 2026. This structure gradually delivers exercisable options over three years, aligning the director’s potential benefit with a longer-term time frame.

Did David Roy Williams buy or sell Crexendo (CXDO) shares in this Form 4 filing?

The Form 4 shows an acquisition of stock options, not a market trade in common shares. The transaction is coded as a grant, award, or other acquisition, indicating compensation-related options rather than an open-market stock purchase or sale.

What ownership does David Roy Williams report after this Crexendo (CXDO) option grant?

After the reported transaction, David Roy Williams is shown as directly holding 10,000 stock options. This reflects the full amount of the grant, though the options will become exercisable over time as they vest in monthly installments starting in April 2026.

How is the transaction in Crexendo (CXDO) options classified in the Form 4?

The transaction is classified as a derivative security grant with code “A”, described as a grant, award, or other acquisition. It involves 10,000 stock options at an exercise price of $6.47 per share, reported as directly owned by David Roy Williams.